Shares of Vera Therapeutics (NASDAQ:VERA) lost ~20% on Friday to reach a new 52-week low, in a move attributed to a potential market launch of a rival kidney disease therapy from Otsuka Holdings ...

The former chief technologist of the Consumer Financial Protection Bureau alleged in a legal filing that the Trump administration is on the verge of deleting a database with sensitive financial ...

Ray Dalio’s Bridgewater Associates, which is one of the world’s largest hedge funds, made significant adjustments to its portfolio in the ...

Companies are trying to influence the new administration — and showcasing public displays of compliance with Trump’s agenda ...